A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus

Louis Cassany, David Gucik-Derigny, Jerome Cieslak, David Henry, Roberto Franco, Alejandra Ferreira De Loza, Hector Rios, Loic Olcomendy, Antoine Pirog, Yannick Bornat, Sylvie Renaud, Bogdan Catargi

Producción científica: Capítulo del libro/informe/acta de congresoContribución a la conferenciarevisión exhaustiva

6 Citas (Scopus)

Resumen

The paper addresses the development of an artificial pancreas for the treatment of Type 1 Diabetes Mellitus, and more precisely the design of a control law for insulin delivery. As opposed to current existing solutions, the proposed approach is patient-independent, so it tackles the variability of the patients. Robust margins and worst-case performance are also established by means of the H∞/μ-analysis theory. The proposed solution is evaluated through the high-fidelity UVA/Padova simulator accepted by the US Food and Drug Administration as a substitute for pre-clinical testing of new treatment strategies.

Idioma originalInglés
Título de la publicación alojada2021 European Control Conference, ECC 2021
EditorialInstitute of Electrical and Electronics Engineers Inc.
Páginas327-332
Número de páginas6
ISBN (versión digital)9789463842365
DOI
EstadoPublicada - 2021
Publicado de forma externa
Evento2021 European Control Conference, ECC 2021 - Delft, Países Bajos
Duración: 29 jun. 20212 jul. 2021

Serie de la publicación

Nombre2021 European Control Conference, ECC 2021

Conferencia

Conferencia2021 European Control Conference, ECC 2021
País/TerritorioPaíses Bajos
CiudadDelft
Período29/06/212/07/21

Nota bibliográfica

Publisher Copyright:
© 2021 EUCA.

Huella

Profundice en los temas de investigación de 'A Robust Control solution for Glycaemia Regulation of Type-1 Diabetes Mellitus'. En conjunto forman una huella única.

Citar esto